- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04216875
Best Practice Study of Diabetes Type 2 Management in Primary Care in Switzerland
Optimisation of Treatment of Chronic Patients With Diabetes Mellitus Type 2 in Primary Care (Qualiccare Begleitforschung Zur Optimierung Der Behandlung Von Chronischen Patienten Mit Diabetes Mellitus Typ 2 in Der Grundversorgung)
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Information of the primary care practices regarding the background and goal of the project by means of a letter and informative documentation.
Recruitment of primary care practices, divided into three different practice organisations (individual practices and group practices run on a private basis and with financial autonomy, as well as forms of joint practices with employed physicians without financial autonomy).
A signed contract between QualiCCare and participating primary care practices regulates the collaboration.
Procedure:
A baseline documentation takes place retrospectively from the training/workshop for the past 12 months, and a second, prospective documentation of the treatment is done during the following 12 months.
Training of the participating general practioners (GP) and practice coordinator on the project including evaluation software, data entry and background to the criteria.
Documentation of the treatment quality of all patients with diabetes mellitus type 2 in a practice structure that meets the inclusion criteria according to the score criteria (baseline).
After 12 months, the treatment quality of the included patients with diabetes type 2 is recorded again using the same score.
Study Type
Enrollment (Actual)
Contacts and Locations
Study Locations
-
-
SG
-
Saint Gallen, SG, Switzerland
- Hausarztmedizin KSSG
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Child
- Adult
- Older Adult
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
Study population comprises two different kinds of primary care practices who either get the intervention or have no intervention (4 groups in total):
single practices with one general practioner and group practices with several general practitioners. On the practice level, the study population comprises all diabetes patients who correspond to the inclusion criteria.
Description
Inclusion Criteria:
- all patients in the primary care practice with a diabetes diagnosis, meaning their patient record shows that the patient either had an HbA1c value higher than 6.4 percent, takes insulin or oral antidiabetics and is treated at least during nine months in the participating primary care practice.
Exclusion Criteria:
- treatment in participating primary care practice during less than nine months (due to change of primary care provider, death, diabetes treatment solely by specialist);
- patients who do not give their patient consent to participate in study;
- patients whom the primary care provider excludes from study due to frailty, end of life or other reasons.
Study Plan
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
---|---|
single primary care practices intervention
Independent primary care practices with one single medical doctor in the practice, usually ther owner of the practice working in his responsibility following the best practice procedure of the diabetes score.
|
Practice adherence to best practice guidelines treating diabetes patients in different primary care practices is shown in this before- and after observational study
Other Names:
|
primary care group practice intervention
Independent primary care practices with more than one medical doctor working in their responsibility following the best practice procedure of the diabetes score.
|
Practice adherence to best practice guidelines treating diabetes patients in different primary care practices is shown in this before- and after observational study
Other Names:
|
single primary care practices no intervention
Independent primary care practices with one single medical doctor in the practice, usually ther owner of the practice working in his responsibility without the intervention (not using Diabetes score)
|
|
primary care group practice no intervention
Independent primary care practices with more than one medical doctor working in their responsibility without the intervention (not using Diabetes score).
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Change in score result before and after the introduction of the diabetes score criteria for treatment of diabetes patients in the primary care setting
Time Frame: one year
|
The change is measured at baseline, before the introduction of the diabetes score criteria and one year after the introduction. There are 8 score criteria for the good diabetes management in primary care (such as 1x/y lifestyle consultation, 1x/foot control, etc). Each criteria gets a certain number of points if 80% of the participating patients are treated in accordance to the given criteria. In total, a maximum of 100 points can be achieved. The objective is to achieved a minimum of 70% (= 70 points). |
one year
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Evaluation of feasibility of the implementation of the diabetes score criteria in different primary care practice types
Time Frame: one year
|
In order to test the feasibility of the use in different primary care practice types, the diabetes score criteria (as described above) are used in independent single practices and group practices.
The above mentioned diabetes score consists of 8 score criteria concerning the diabetes management in primary care.
The maximum amount of points are 100.
it is desirable to achieve 70/100 points, whereas the points are attributed if 80% of the participating diabetes patients in the practice are treated according the the criteria.
|
one year
|
Comparison of the diabetes treatment in regards to the different primary care settings
Time Frame: one year
|
The resulting average score value of the diabetes treatment using the above described and mentioned diabetes score criteria in independent single primary care practices is compared with the resulting average score value of the diabetes treatment in group practices.
The higher the score value, the better the treatment of diabetes patients in the respective practice structure (single or group practice).
|
one year
|
Evaluation of practice tool used for the documentation and evaluation of the diabetes score
Time Frame: one year
|
The participating primary care practices evaluate the practice tool and give feedback in regards to practicality and applicability in the respective practice setting
|
one year
|
Collaborators and Investigators
Sponsor
Collaborators
Investigators
- Principal Investigator: Emanuel Christ, Prof., University Hospital, Basel, Switzerland
Publications and helpful links
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- QualiCCare Diabetes III
- BASEC Nr. 2017-01340 (Other Identifier: swissethics)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Diabetes Mellitus, Type 2
-
SanofiCompletedType 1 Diabetes Mellitus-Type 2 Diabetes MellitusHungary, Russian Federation, Germany, Poland, Japan, United States, Finland
-
Mannkind CorporationTerminatedType 2 Diabetes Mellitus | Type 1 Diabetes MellitusUnited States
-
RWTH Aachen UniversityBoehringer IngelheimCompletedDiabetes Mellitus Type 2 (T2DM)Germany
-
Scripps Whittier Diabetes InstituteSan Diego State UniversityCompletedType 2 Diabetes Mellitus (T2DM)United States
-
Griffin HospitalCalifornia Walnut CommissionCompletedDIABETES MELLITUS TYPE 2United States
-
University Hospital Inselspital, BerneCompletedType 2 Diabetes MellitusSwitzerland
-
India Diabetes Research Foundation & Dr. A. Ramachandran...CompletedTYpe 2 Diabetes MellitusIndia
-
US Department of Veterans AffairsAmerican Diabetes AssociationCompletedType 2 Diabetes MellitusUnited States
-
Dexa Medica GroupCompletedType-2 Diabetes MellitusIndonesia
-
AstraZenecaRecruiting
Clinical Trials on Best Practice Diabetes Management in Primary Care
-
University Hospital, GenevaHaute Ecole de Santé Vaud; University of Applied Sciences of Western Switzerland and other collaboratorsRecruiting
-
Fundacio d'Investigacio en Atencio Primaria Jordi...CompletedType 2 Diabetes | Cardiovascular Risk Factor | GenderSpain
-
Boston Medical CenterNational Institute on Alcohol Abuse and Alcoholism (NIAAA)Active, not recruiting
-
Emory UniversityNational Cancer Institute (NCI); National Center for Complementary and Integrative...RecruitingLymphoma | Multiple MyelomaUnited States
-
Ohio State University Comprehensive Cancer CenterRecruitingHematopoietic and Lymphoid Cell Neoplasm | Malignant Solid NeoplasmUnited States
-
ECOG-ACRIN Cancer Research GroupNational Cancer Institute (NCI)Active, not recruitingAcute Promyelocytic Leukemia With PML-RARA | t(15;17)United States, Puerto Rico
-
University of North Carolina, Chapel HillAgency for Healthcare Research and Quality (AHRQ)CompletedCardiovascular Disease
-
Massachusetts General HospitalCenters for Disease Control and Prevention; Harvard School of Public Health... and other collaboratorsCompleted
-
HealthPartners InstitutePatient-Centered Outcomes Research InstituteCompleted
-
Carlos III Health InstituteHealth Department of the Basque GovernmentCompleted